ARCHIVES

In Brief: Calabresi Named To President’s Cancer Panel; Mays Leaves NCI Technology Office For IVAX

This article is from The Cancer Letter archive.

Vol. 21 No. 18 | May 5, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013

M.D. Anderson Stops Establishing Satellite Clinics, Views Role as Working With All Texas Oncologists

November 22, 1996

NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity

February 27, 1981

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

House Science Committee Chairman Questions NIH Budget Increases.

February 2, 2001

NCI STRAP Grants Aim To Move Research Quickly To Clinical Trials

October 1, 2010